Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study

समान संसाधन

• Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release
  द्वारा: Trivedi, Madhukar H., और अन्य
  प्रकाशित: (2010)
• Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
  द्वारा: Watanabe, Yoshinori, और अन्य
  प्रकाशित: (2018)
• Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study
  द्वारा: Rothschild, Anthony J., और अन्य
  प्रकाशित: (2009)
• Correlation between patient and clinician assessments of depression severity in the PREVENT study
  द्वारा: Dunlop, Boadie W., और अन्य
  प्रकाशित: (2010)
• Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder
  द्वारा: Dunlop, Boadie W., और अन्य
  प्रकाशित: (2010)